Imaging Diagnostic Systems (IDSI) of Plantation, FL, will showthe latest work on its Computed Tomography Laser Mammography (CTLM)system. The system uses near-infrared lasers to obtain slice-basedmammography data that can be manipulated like other 3-D
Imaging Diagnostic Systems (IDSI) of Plantation, FL, will showthe latest work on its Computed Tomography Laser Mammography (CTLM)system. The system uses near-infrared lasers to obtain slice-basedmammography data that can be manipulated like other 3-D data sets.
At the 1994 RSNA show, the company showed the first images ithad acquired with the technique (SCAN 11/9/94). Since then, IDSIhas improved the system's optics, mechanics and imaging software.By the end of the year, the company plans to install a second-generationprototype system in Strax Clinic in Fort Lauderdale for continuedclinical evaluation.
The company's goal is to demonstrate that CTLM can produce diagnosticallyrelevant images that are comparable to x-ray mammography. It willsoon be filing an application with the Food and Drug Administrationfor a clinical protocol to test its technology, according to CEORichard Grable. IDSI hopes to establish six beta sites in 1996.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.